The Effect of a Patient Education Program on Vitamin D Levels and Health Beliefs Regarding Vitamin D Use
1 other identifier
interventional
60
1 country
1
Brief Summary
Background and Rationale: Vitamin D deficiency is a major public health concern. While clinical guidelines provide treatment protocols, medication adherence remains a significant barrier to achieving target serum levels. This study aims to evaluate whether a structured patient education program can improve health beliefs and adherence, ultimately leading to better clinical outcomes. Study Procedures: Participants identified with Vitamin D levels \<30 ng/mL will be randomized into two groups. Intervention Group: Patients will receive a face-to-face education session covering the importance of Vitamin D, correct usage, and potential side effects. They will also receive informative brochures and monthly follow-up phone calls to support adherence. Control Group: Patients will receive standard clinical care without additional structured education.Evaluation:Adherence will be monitored using the Medication Possession Ratio (MPR). Serum 25(OH)D levels and Vitamin D Health Belief Scale scores will be reassessed at the 6-month mark to compare the effectiveness of the intervention against the control group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2026
CompletedFirst Submitted
Initial submission to the registry
March 18, 2026
CompletedFirst Posted
Study publicly available on registry
April 17, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
ExpectedApril 17, 2026
April 1, 2026
3 months
March 18, 2026
April 10, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in Serum 25(OH)D Levels
Assessment of Vitamin D status through serum laboratory analysis
Baseline and 3 months
Change in Medication Possession Ratio (MPR)
Adherence measured by MPR. Target is defined as \>% 80
Baseline and 3 months
Study Arms (2)
Control group
NO INTERVENTIONEducation group
ACTIVE COMPARATORInterventions
This study implements a pharmacist-led patient education program designed to improve treatment adherence and health beliefs in individuals with vitamin D deficiency (25(OH)D \< 30 ng/mL). The intervention begins with the collection of sociodemographic data and the administration of the Vitamin D Health Belief Scale to establish a baseline. The core intervention involves providing the intervention group (n=30) with structured oral counseling and written educational materials (patient brochures) regarding the clinical importance and proper usage of vitamin D. In contrast, the control group receives standard care. Three months post-intervention, follow-up assessments are conducted via telephone to re-evaluate health beliefs and measure treatment adherence using the Medication Possession Ratio (MPR). The primary success criteria are achieving an MPR ≥ 8
Eligibility Criteria
You may qualify if:
- Female,
- Aged 18 years and older,
- Hypothyroid disease,
- Serum vitamin D level \< 30 ng/mL,
- Providing written informed consent to participate in the study.
You may not qualify if:
- Male ,
- Under the age of 18,
- Patients who do not provide written informed consent,
- Serum vitamin D levels \> 30 ng/mL
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
KTU Faculty of Medicine
Trabzon, Turkey (Türkiye)
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Assistant
Study Record Dates
First Submitted
March 18, 2026
First Posted
April 17, 2026
Study Start
November 1, 2025
Primary Completion
February 1, 2026
Study Completion (Estimated)
June 1, 2026
Last Updated
April 17, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared to ensure the confidentiality and privacy of the participants, in accordance with the institutional ethics committee's guidelines and local data protection regulations. The data collected during this study contains sensitive clinical information belonging to a specific patient population, and the informed consent obtained from the participants did not include permission for the public sharing or secondary use of their individual raw data by third parties